Nausea and Vomiting Treatment Market Report

Global and Region Nausea and Vomiting Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：228
  • REPORT CODE：GMM942166
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nausea and Vomiting Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nausea and Vomiting Treatmentmarket, defines the market attractiveness level of Nausea and Vomiting Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nausea and Vomiting Treatment industry, describes the types of Nausea and Vomiting Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nausea and Vomiting Treatment market and the development prospects and opportunities of Nausea and Vomiting Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nausea and Vomiting Treatment market in Chapter 13.

    By Player:

    • Merck and Co Inc

    • Heron Therapeutics

    • Unimed Pharmaceuticals (AbbVie Inc)

    • Helsinn Group

    • Tesaro

    • Atnahs Pharma UK Limited

    • Sanofi

    • Duchesnay

    • Taiji group

    • Qilu Pharma

    • Mylan

    • Teva Pharmaceutical Industries Ltd

    • Kyowa Kirin

    • Novartis

    By Type:

    • Serotonin Receptor Antagonist

    • Neurokinin NK1 Receptor Antagonist

    • Other

    By End-User:

    • CINV

    • PONV

    • Motion Sickness

    • Pregnancy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nausea and Vomiting Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nausea and Vomiting Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nausea and Vomiting Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nausea and Vomiting Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nausea and Vomiting Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.2 United States Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.3 Europe Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.4 China Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.5 Japan Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.6 India Nausea and Vomiting Treatment Consumption (2017-2022)

    • 7.7 South Korea Nausea and Vomiting Treatment Consumption (2017-2022)

    8 Region and Country-wise Nausea and Vomiting Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.4 China Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.6 India Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Nausea and Vomiting Treatment Consumption Forecast (2022-2028)

    9 Global Nausea and Vomiting Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Nausea and Vomiting Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Serotonin Receptor Antagonist Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Neurokinin NK1 Receptor Antagonist Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nausea and Vomiting Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global CINV Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global PONV Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Motion Sickness Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pregnancy Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Nausea and Vomiting Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Nausea and Vomiting Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Serotonin Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Neurokinin NK1 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nausea and Vomiting Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global CINV Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global PONV Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Motion Sickness Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pregnancy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nausea and Vomiting Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nausea and Vomiting Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nausea and Vomiting Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nausea and Vomiting Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nausea and Vomiting Treatment Market Competitive Analysis

    • 14.1 Merck and Co Inc

      • 14.1.1 Merck and Co Inc Company Details

      • 14.1.2 Merck and Co Inc Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck and Co Inc Nausea and Vomiting Treatment Product and Service

    • 14.2 Heron Therapeutics

      • 14.2.1 Heron Therapeutics Company Details

      • 14.2.2 Heron Therapeutics Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Heron Therapeutics Nausea and Vomiting Treatment Product and Service

    • 14.3 Unimed Pharmaceuticals (AbbVie Inc)

      • 14.3.1 Unimed Pharmaceuticals (AbbVie Inc) Company Details

      • 14.3.2 Unimed Pharmaceuticals (AbbVie Inc) Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Unimed Pharmaceuticals (AbbVie Inc) Nausea and Vomiting Treatment Product and Service

    • 14.4 Helsinn Group

      • 14.4.1 Helsinn Group Company Details

      • 14.4.2 Helsinn Group Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Helsinn Group Nausea and Vomiting Treatment Product and Service

    • 14.5 Tesaro

      • 14.5.1 Tesaro Company Details

      • 14.5.2 Tesaro Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Tesaro Nausea and Vomiting Treatment Product and Service

    • 14.6 Atnahs Pharma UK Limited

      • 14.6.1 Atnahs Pharma UK Limited Company Details

      • 14.6.2 Atnahs Pharma UK Limited Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Atnahs Pharma UK Limited Nausea and Vomiting Treatment Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Nausea and Vomiting Treatment Product and Service

    • 14.8 Duchesnay

      • 14.8.1 Duchesnay Company Details

      • 14.8.2 Duchesnay Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Duchesnay Nausea and Vomiting Treatment Product and Service

    • 14.9 Taiji group

      • 14.9.1 Taiji group Company Details

      • 14.9.2 Taiji group Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Taiji group Nausea and Vomiting Treatment Product and Service

    • 14.10 Qilu Pharma

      • 14.10.1 Qilu Pharma Company Details

      • 14.10.2 Qilu Pharma Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Qilu Pharma Nausea and Vomiting Treatment Product and Service

    • 14.11 Mylan

      • 14.11.1 Mylan Company Details

      • 14.11.2 Mylan Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Mylan Nausea and Vomiting Treatment Product and Service

    • 14.12 Teva Pharmaceutical Industries Ltd

      • 14.12.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.12.2 Teva Pharmaceutical Industries Ltd Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Teva Pharmaceutical Industries Ltd Nausea and Vomiting Treatment Product and Service

    • 14.13 Kyowa Kirin

      • 14.13.1 Kyowa Kirin Company Details

      • 14.13.2 Kyowa Kirin Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Kyowa Kirin Nausea and Vomiting Treatment Product and Service

    • 14.14 Novartis

      • 14.14.1 Novartis Company Details

      • 14.14.2 Novartis Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Novartis Nausea and Vomiting Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nausea and Vomiting Treatment

    • Figure Nausea and Vomiting Treatment Picture

    • Table Global Nausea and Vomiting Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nausea and Vomiting Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nausea and Vomiting Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nausea and Vomiting Treatment Consumption by Country (2017-2022)

    • Figure United States Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nausea and Vomiting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Nausea and Vomiting Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nausea and Vomiting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serotonin Receptor Antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Neurokinin NK1 Receptor Antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global CINV Consumption and Growth Rate (2017-2022)

    • Figure Global PONV Consumption and Growth Rate (2017-2022)

    • Figure Global Motion Sickness Consumption and Growth Rate (2017-2022)

    • Figure Global Pregnancy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Serotonin Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurokinin NK1 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CINV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PONV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Motion Sickness Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pregnancy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nausea and Vomiting Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nausea and Vomiting Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck and Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck and Co Inc Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck and Co Inc Nausea and Vomiting Treatment Product and Service

    • Table Heron Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Heron Therapeutics Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Nausea and Vomiting Treatment Product and Service

    • Table Unimed Pharmaceuticals (AbbVie Inc) (Foundation Year, Company Profile and etc.)

    • Table Unimed Pharmaceuticals (AbbVie Inc) Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Unimed Pharmaceuticals (AbbVie Inc) Nausea and Vomiting Treatment Product and Service

    • Table Helsinn Group (Foundation Year, Company Profile and etc.)

    • Table Helsinn Group Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Group Nausea and Vomiting Treatment Product and Service

    • Table Tesaro (Foundation Year, Company Profile and etc.)

    • Table Tesaro Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Nausea and Vomiting Treatment Product and Service

    • Table Atnahs Pharma UK Limited (Foundation Year, Company Profile and etc.)

    • Table Atnahs Pharma UK Limited Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atnahs Pharma UK Limited Nausea and Vomiting Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Nausea and Vomiting Treatment Product and Service

    • Table Duchesnay (Foundation Year, Company Profile and etc.)

    • Table Duchesnay Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Duchesnay Nausea and Vomiting Treatment Product and Service

    • Table Taiji group (Foundation Year, Company Profile and etc.)

    • Table Taiji group Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taiji group Nausea and Vomiting Treatment Product and Service

    • Table Qilu Pharma (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharma Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharma Nausea and Vomiting Treatment Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Nausea and Vomiting Treatment Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Nausea and Vomiting Treatment Product and Service

    • Table Kyowa Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Kirin Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Kirin Nausea and Vomiting Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Nausea and Vomiting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Nausea and Vomiting Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US